Prevention by epidural Injection of postherpetic Neuralgia in the Elderly

ISRCTN ISRCTN32866390
DOI https://doi.org/10.1186/ISRCTN32866390
Secondary identifying numbers NWO 945-02-009
Submission date
23/10/2003
Registration date
24/11/2003
Last edited
31/03/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Theo Verheij
Scientific

Julius Center for Health Sciences and Primary Care
University Medical Center
PO Box 85060
Utrecht
3500 AB
Netherlands

Phone +31 (0)30 253 8188
Email T.J.M.Verheij@med.uu.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typePrevention
Scientific title
Study acronymPINE
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHerpes zoster/postherpetic neuralgia
InterventionIndex group: Standard treatment (antiviral and analgesic medication) plus epidural injection of local anaesthetics and corticosteroids.

Control group: Standard treatment (antiviral and analgesic medication)
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Methylprednisolone-acetate, bupivacaine
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2004
Completion date01/01/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants550
Key inclusion criteriaElderly patients (age >50 years) with acute herpes zoster (skin lesions <7 days) below dermatome C6 in primary care
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2004
Date of final enrolment01/01/2005

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Julius Center for Health Sciences and Primary Care
Utrecht
3500 AB
Netherlands

Sponsor information

Julius Center for Health Sciences and Primary Care (The Netherlands)
Hospital/treatment centre

University Medical Center
Utrecht
PO Box 85060
Utrecht
3500 AB
Netherlands

Phone +31 (0)30 253 8788
Email w.opstelten@med.uu.nl
ROR logo "ROR" https://ror.org/0575yy874

Funders

Funder type

Research organisation

The Netherlands Organisation for Scientific Research (The Netherlands) (ref: 945-02-009)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 26/01/2004 Yes No
Results article Results 21/01/2006 Yes No